Global (United States, European Union and China) Nicotine Transdermal Patches Market Research Report 2019-2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Nicotine Transdermal Patches Market Size Growth Rate by Type (2019-2025)
- 1.3.2 21mg/patch
- 1.3.3 14mg/patch
- 1.3.4 7mg/patch
- 1.4 Market Segment by Application
- 1.4.1 Global Nicotine Transdermal Patches Market Share by Application (2019-2025)
- 1.4.2 Age Below 30
- 1.4.3 Age 30-50
- 1.4.4 Age above 50
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Nicotine Transdermal Patches Market Size
- 2.1.1 Global Nicotine Transdermal Patches Revenue 2014-2025
- 2.1.2 Global Nicotine Transdermal Patches Sales 2014-2025
- 2.2 Nicotine Transdermal Patches Growth Rate by Regions
- 2.2.1 Global Nicotine Transdermal Patches Sales by Regions 2014-2019
- 2.2.2 Global Nicotine Transdermal Patches Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Nicotine Transdermal Patches Sales by Manufacturers
- 3.1.1 Nicotine Transdermal Patches Sales by Manufacturers 2014-2019
- 3.1.2 Nicotine Transdermal Patches Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Nicotine Transdermal Patches Revenue by Manufacturers (2014-2019)
- 3.2.2 Nicotine Transdermal Patches Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Nicotine Transdermal Patches Market Concentration Ratio (CR5 and HHI)
- 3.3 Nicotine Transdermal Patches Price by Manufacturers
- 3.4 Key Manufacturers Nicotine Transdermal Patches Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Nicotine Transdermal Patches Market
- 3.6 Key Manufacturers Nicotine Transdermal Patches Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 21mg/patch Sales and Revenue (2014-2019)
- 4.1.2 14mg/patch Sales and Revenue (2014-2019)
- 4.1.3 7mg/patch Sales and Revenue (2014-2019)
- 4.2 Global Nicotine Transdermal Patches Sales Market Share by Type
- 4.3 Global Nicotine Transdermal Patches Revenue Market Share by Type
- 4.4 Nicotine Transdermal Patches Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Nicotine Transdermal Patches Sales by Application
6 United States
- 6.1 United States Nicotine Transdermal Patches Breakdown Data by Company
- 6.2 United States Nicotine Transdermal Patches Breakdown Data by Type
- 6.3 United States Nicotine Transdermal Patches Breakdown Data by Application
7 European Union
- 7.1 European Union Nicotine Transdermal Patches Breakdown Data by Company
- 7.2 European Union Nicotine Transdermal Patches Breakdown Data by Type
- 7.3 European Union Nicotine Transdermal Patches Breakdown Data by Application
8 China
- 8.1 China Nicotine Transdermal Patches Breakdown Data by Company
- 8.2 China Nicotine Transdermal Patches Breakdown Data by Type
- 8.3 China Nicotine Transdermal Patches Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Nicotine Transdermal Patches Breakdown Data by Company
- 9.2 Rest of World Nicotine Transdermal Patches Breakdown Data by Type
- 9.3 Rest of World Nicotine Transdermal Patches Breakdown Data by Application
- 9.4 Rest of World Nicotine Transdermal Patches Breakdown Data by Countries
- 9.4.1 Rest of World Nicotine Transdermal Patches Sales by Countries
- 9.4.2 Rest of World Nicotine Transdermal Patches Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 GSK
- 10.1.1 GSK Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Nicotine Transdermal Patches
- 10.1.4 Nicotine Transdermal Patches Product Introduction
- 10.1.5 GSK Recent Development
- 10.2 Dr Reddy's Laboratories
- 10.2.1 Dr Reddy's Laboratories Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Nicotine Transdermal Patches
- 10.2.4 Nicotine Transdermal Patches Product Introduction
- 10.2.5 Dr Reddy's Laboratories Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Nicotine Transdermal Patches Sales Channels
- 11.2.2 Nicotine Transdermal Patches Distributors
- 11.3 Nicotine Transdermal Patches Customers
12 Market Forecast
- 12.1 Global Nicotine Transdermal Patches Sales and Revenue Forecast 2019-2025
- 12.2 Global Nicotine Transdermal Patches Sales Forecast by Type
- 12.3 Global Nicotine Transdermal Patches Sales Forecast by Application
- 12.4 Nicotine Transdermal Patches Forecast by Regions
- 12.4.1 Global Nicotine Transdermal Patches Sales Forecast by Regions 2019-2025
- 12.4.2 Global Nicotine Transdermal Patches Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
In 2019, the market size of Nicotine Transdermal Patches is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Nicotine Transdermal Patches.
This report studies the global market size of Nicotine Transdermal Patches, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Nicotine Transdermal Patches sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
GSK
Dr Reddy's Laboratories
...
Market Segment by Product Type
21mg/patch
14mg/patch
7mg/patch
Market Segment by Application
Age Below 30
Age 30-50
Age above 50
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Nicotine Transdermal Patches status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Nicotine Transdermal Patches manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Nicotine Transdermal Patches are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025